SCN10A and cancer: Our results indicated that the intraperitoneal administration of varenicline to cancer-bearing mice expressing PSAM4-GlyR diminished their weight-bearing deficits, not only highlighting the efficacy of this system but also confirming the involvement of the NaV1.8-positive neurons in CIBP (Fig. 8A).